FAAH rs324420 Polymorphism in People With Opioid and Methamphetamine Use Disorders: Psychological Associations
Özlem Erekli‐Arat, Meltem Tepe, Selin Özkan‐Kotiloğlu, Mustafa Danışman, Dilek Kaya‐Akyüzlü · 2026
Read FAAH rs324420 Polymorphism in People With Opioid and Methamphetamine Use Disorders: Psychological Associations by Özlem Erekli‐Arat, Meltem Tepe, Selin Özkan‐Kotiloğlu, Mustafa Danışman, Dilek Kaya‐Akyüzlü (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13176081.txt.
Description
Özlem Erekli-Arat and co-authors test a gene variant in people with drug use disorders in a 2026 study. The gene codes for FAAH, an enzyme that breaks down the brain's own cannabis-like signals and shapes behavior. The team recruited 562 people: methamphetamine users, opioid users, users of both, and healthy volunteers.
Everyone gave DNA and filled scales for impulsiveness, craving, withdrawal, anxiety, and depression. One genotype of the variant appeared less often in the disorder groups and cut the odds of illness by roughly forty percent against the reference type. Craving scores ran highest in the group using both drugs. The authors read the variant as mildly protective, while noting that craving care may matter most for combined users.
Catalog record
| CREATOR | Özlem Erekli‐Arat, Meltem Tepe, Selin Özkan‐Kotiloğlu, Mustafa Danışman, Dilek Kaya‐Akyüzlü |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 51 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |